PLETHICO

Plethico Pharmaceuticals Limited has informed the Exchange that an Extra-Ordinary General Meeting of the members of the Company held on April 19, 2010 following decision have been approved by the members of the Company :- (1) The raise funds to the extent of US$ 100 Million or its Indian rupees equivalent by way of issuance of equity shares and / or FCCB and / or GDR and / or other securities convertible into equity shares and / or such other equity-linked instruments.

Plethico Pharmaceuticals Limited has informed the Exchange that the Annual General Meeting of the members of the Company held on June 26, 2009 and following decision have been taken: (1). Company has declared the dividend for the year 2008 of Rs. 2.50 per equity share i.e @ 25%. (2). Dr. G.N. Qazi arid Mr. Pramod Shrivastava are re-appointed as Director of the Company. (3). M/s. N. P. Gandhi & Co. has been appointed as Statutory Auditors of the Company. (4). Authority to Board of Directors u/s 372A of the Companies Act, 1956 for Investment in Tricon Holdings FZE, UAE.

Plethico Pharmaceuticals Limited has informed the Exchange that at the Extra-Ordinary General Meeting of the members of the Company held on March 31, 2009, the following decision have been approved by the members of the Company: (1) The issuance of equity shares and/or FCCB and/or GDR and/or other securities convertible into equity shares and/or such other equity-linked instruments to an extent of US$ 40 Million Indian Rupee equivalent. (2) Authority to Board of Directors to borrow in excess of paid-up capital and free reserve to an extent of Rs. 1200 Crores (Rupees One Thousand Two Hundred Cr

Plethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 09, 2009 decided the following: [1] To borrow, subject to the approval of the Company in general meeting, to the extent of Rs.1200 crores, notwithstanding that the moneys to be borrowed together with the money's already borrowed by the Company (apart from temporary loans, if any, obtained from the Company's bankers in the ordinary course of business) will exceed the aggregate of the paid-up capital of the Company and its free reserves; [2] To consider, subject to t

Plethico Pharmaceuticals Limited has informed the Exchange regarding the decisions taken at the Annual General Meeting of the members of the Company held on June 27, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Plethico_Outcome_27062008.zip target=NEW> For more details click here.</a>

Plethico Pharmaceuticals Limited has informed the Exchange that "the 14th Annual General Meeting of the members of the Company held on Friday the 30th day of March 2007 at the Registered office of the Company and following decisions have been taken :- (1) Company has declared the dividend for the year 2005-06 of Rs. 2.50 per equity share i.e. @25%. (2) Mr. Ashok Sodhani, Dr. G.N. Qazi, Mr. Pramod K. Shrivastava and Mr. Abhay Suhane are appointed as Director of the Company. (3) The Board of Directors of the Company is authorized to decide sitting fees for attending the board meetings /compensa